These emerging drugs , including Wegovy, a similar compound, and Zaxig , represent a important advancement in addressing type 2 hyperglycemia and supporting weight reduction . They work by imitating the body’s natural incretin signal , enabling to regulate blood levels and reduce appetite . Each